Baseline and Outcome Characteristics of Multiple Valve Surgery Compared with Single Valve Procedures in Mainland China: A Multicenter Experience
Background: To compare baseline and outcome characteristics of multiple valve surgery with single-valve procedures in a multicenter patient population of mainland China.
Methods: From January 2008 to December 2012, data from 14,322 consecutive patients older than 16 years who underwent heart valve surgery at five cardiac surgical centers (except pulmonary valve operations) were collected. The patients were divided into seven subgroups according to the type of valve procedures, and baseline characteristics and postoperative outcomes were contrasted between all seven combinations of single-valve and multiple-valve procedures involving aortic, mitral, and tricuspid valves. Two independent logistic regression analyses were performed and multivariable risk factors for mortality were compared, with emphasis on single-valve versus multiple-valve surgery.
Results: Baseline characteristics for MUV procedures
(n = 8945) shared many differences to those for single-valve procedures (n = 5377). Proportion of females, chronic obstructive pulmonary disease, cerebrovascular disease, renal impairment, congestive heart failure, NHYA class III-IV, atrial fibrillation, pulmonary hypertension, and decreased ejection fraction were more common in MUV subgroups, and smoker, hypertension, dyslipidemia, active infectious endocarditis, and coronary bypass graft was less frequent. In-hospital mortality was higher for MUV as compared with single-valve procedures (2.4% versus 1.6%, P = .007). Preoperative independent predictors for mortality of patients undergoing MUV procedures were age, chronic obstructive pulmonary disease, diabetes mellitus, renal dysfunction, dialysis, congestive heart failure, cardiogenic shock, NYHA class III-IV, mitral stenosis, tricuspid regurgitation, mitral valve replacement, and concomitant CABG. However, risk factors for mortality were relatively different between single-valve and MUV procedures.
Conclusion: Baseline characteristics and epidemiology were different between MUV and single-valve procedures. The in-hospital mortality and postoperative complications for MUV procedures remained considerably higher and determinants of mortality were relatively different across procedures types. These findings serve as a benchmark for further studies, as well as suggest a continued search for explanations of MUV outcomes.
Alsoufi B, Rao V, Borger MA, et al. 2006. Short- and long-term results of triple valve surgery in the modern era. Ann Thorac Surg 81:2172-8.
Bhudia SK, McCarthy PM, Kumpati GS, et al. 2007. Improved outcomes after aortic valve surgery for chronic aortic regurgitation with severe left ventricular dysfunction. J Am Coll Cardiol 49:1465-71.
Brown JM, O’Brien SM, Wu C, et al. 2009. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in The Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 137:82-90.
Chatterjee S, Rankin JS, Gammie JS, et al. 2013. Isolated mitral valve surgery risk in 77,836 patients from the Society of Thoracic Surgeons Database. Ann Thorac Surg 96:1587-95.
De Oliveira NC, David TE, Armstrong S, et al. 2005. Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: an analysis of clinical outcomes. J Thorac Cardiovasc Surg 129:286-90.
Dreyfus GD, Corbi PJ, Chan KM, et al. 2005. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 79:127-32.
El-Essawi A, Hajek T, Skorpil J, et al. 2010. A prospective randomised multicentre clinical comparison of a minimised perfusion circuit versus conventional cardiopulmonary bypass. Eur J Cardiothorac Surg 38:91-7.
Feindel CM, Tufail Z, David TE, et al. 2003. Mitral valve surgery in patients with extensive calcification of the mitral annulus. J Thorac Cardiovasc Surg 126:777-82.
Gammie JS, Sheng S, Griffith BP, et al. 2009. Trends in mitral valve surgery in the United States: results from The Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 87:1431-7.
Gillinov AM, Blackstone EH, Cosgrove DM, et al. 2003. Mitral valve repair with aortic valve replacement is superior to double valve replacement. J Thorac Cardiovasc Surg 125:1372-87.
Hannan EL, Racz M, Culliford AT, et al. 2013. Risk score for predicting in-hospital/30-day mortality for patients undergoing valve and valve/coronary artery bypass graft surgery. Ann Thorac Surg 95:1282-90.
Hosmer DW, Lemeshow, S. 2000. Applied Logistic Regression. New Jersey: John Wiley & Sons. 2000.
Jaussaud N, Gariboldi V, Giorgi R, et al. 2009. Risk of reoperation for aortic bioprosthesis dysfunction. J Heart Valve Dis 18:256-61.
Lee R, Li S, Rankin JS, et al, for the Society of Thoracic Surgeons Adult Cardiac Surgical Database. 2011. Fifteen-year outcome trends for valve surgery in North America. Ann Thorac Surg 91:677-84.
Little RJA, Rubin DB. 2002. Statistical analysis with missing data. 2nd ed. Hoboken, NJ: Wiley-Interscience.
Nkomo VT, Gardin JM, Skelton TN, et al. 2006. Burden of valvular heart diseases: A population-based study. Lancet 368:1005-11.
Nowicki ER, Weintraub RW, Birkmeyer NJO, et al. 2003. Mitral valve repair and replacement in northern New England. Am Heart J 145:1058-62.
Nowicki ER, Birkmeyer NJ, Weintraub RW, et al. 2004. Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in northern New England. Ann Thorac Surg 77:1966-77.
O’Brien SM, Shahian DM, Filardo G, et al. 2009. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Part 2-Isolated Valve Surgery. Ann Thorac Surg 88:S23-42.
Rankin JS, Hammill BG, Ferguson TB, et al. 2006. Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg 131:547-57.
Rankin JS, He X, O’Brien SM, et al. 2013. The Society of Thoracic Surgeons Risk Model for Operative Mortality After Multiple Valve Surgery. Ann Thorac Surg 95:1484-90.
Rankina JS, Thouranib VH, Suric RM, et al. 2013. Associations between valve repair and reduced operative mortality in 21,056 mitral/tricuspid double valve procedures. Eur J Cardiothorac Surg 44:472-7.
Savage EB, Ferguson TB, DiSesa VJ. 2003. Use of mitral valve repair: analysis of contemporary United States experience reported to the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg 75:820-5.
Shahian DM, O’Brien SM, Filardo G, et al. 2009. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Part 3-Valve Plus Coronary Artery Bypass Grafting Surgery. Ann Thorac Surg 88:S43-62.
Shiran A, Sagie A. 2009. Tricuspid regurgitation in mitral valve disease. J Am Coll Cardiol 53:401-8.
Suri RM, Schaff HV, Dearani JA, et al. 2006. Recurrent mitral regurgitation after repair: should the mitral valve be rerepaired? J Thorac Cardiovasc Surg 132:1390-7.
Talwar S, Mathur A, Choudhary SK, et al. 2007. Aortic valve replacement with mitral valve repair compared with combined aortic and mitral valve replacement. Ann Thorac Surg 84:1219-25.
Taylor NE, O’Brien S, Edwards FH, et al. 2005. Relationship between race and mortality and morbidity after valve replacement surgery. Circulation 111:1305-12.
Vassileva CM, Shabosky J, Boley T, et al. 2012. Tricuspid valve surgery: the past 10 years from the Nationwide Inpatient Sample (NIS) database. J Thorac Cardiovasc Surg 143:1043-9.
Vassileva CM, Li S, Thourani VH, et al. 2014. Outcome characteristics of multiple valve surgery: comparison to single valves. Innovations 9:27-32.
Zegdi R, Sleilaty G, Latrémouille C, et al. 2008. Reoperation for failure of mitral valve repair in degenerative disease: a single-center experience. Ann Thorac Surg 86:1480-4.
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).